Singh K, Hibbert B, Singh B, Carson K, Premaratne M, Le May M, et al. Meta-analysis of admission hyperglycaemia in acute myocardial infarction patients treated with primary angioplasty: a cause or a marker of mortality? Eur Heart J Cardiovasc Pharmacother. 2015;1(4):220–8.

Article  PubMed  Google Scholar 

Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426–32.

Article  PubMed  Google Scholar 

Mebazaa A, Gayat E, Lassus J, Meas T, Mueller C, Maggioni A, et al. Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol. 2013;61(8):820–9.

Article  PubMed  Google Scholar 

Itzhaki Ben Zadok O, Kornowski R, Goldenberg I, Klempfner R, Toledano Y, Biton Y, et al. Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure. Cardiovasc Diabetol. 2017;16(1):102.

Article  PubMed  PubMed Central  Google Scholar 

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (2019)NICE guideline NG128. Last updated 13 April 2022 https://www.nice.org.uk/guidance/ng128/chapter/Recommendations

Acute coronary syndromes (2020) NICE guideline NG185 https://www.nice.org.uk/guidance/ng185/chapter/Recommendations#hyperglycaemia-in-acute-coronary-syndromes

Collet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2020;42(14):1289–367.

Article  Google Scholar 

Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O’Dea H, Stranks SN, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100(12):4490–7.

Article  PubMed  Google Scholar 

Roberts GW, Larwood C, Krinsley JS. Quantification of stress-induced hyperglycaemia associated with key diagnostic categories using the stress hyperglycaemia ratio. Diabetic Med J Br Diabetic Assoc. 2022;39(10): e14930.

Article  Google Scholar 

Li L, Zhao M, Zhang Z, Zhou L, Zhang Z, Xiong Y, et al. Prognostic significance of the stress hyperglycemia ratio in critically ill patients. Cardiovasc Diabetol. 2023;22(1):275.

Article  PubMed  PubMed Central  Google Scholar 

Huang YW, An YH, Yin XS, Li ZP. Association of the stress hyperglycemia ratio and clinical outcomes in patients with cardiovascular diseases: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2022;26(24):9258–69.

PubMed  Google Scholar 

González P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 2023;24(11):9352.

Article  PubMed  PubMed Central  Google Scholar 

Marfella R, Federici M, Paolisso G. Editorial: hyperglycemia and coronary artery diseases: physio-pathological findings and therapeutic implications. Front Pharmacol. 2022. https://doi.org/10.3389/fphar.2022.901815.

Article  PubMed  PubMed Central  Google Scholar 

Del Turco S, Basta G. An update on advanced glycation endproducts and atherosclerosis. BioFactors. 2012;38(4):266–74.

Article  PubMed  Google Scholar 

Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JCM, Hoekstra JBL. Hyperglycemia: a prothrombotic factor? J Thromb Haemost. 2010;8(8):1663–9.

Article  PubMed  Google Scholar 

Soma P, Swanepoel AC, du Plooy JN, Mqoco T, Pretorius E. Flow cytometric analysis of platelets type 2 diabetes mellitus reveals ‘angry’ platelets. Cardiovasc Diabetol. 2016;15(1):52.

Article  PubMed  PubMed Central  Google Scholar 

Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A. 2000;97(22):12222–6.

Article  PubMed  PubMed Central  Google Scholar 

Pandolfi A, Giaccari A, Cilli C, Alberta MM, Morviducci L, De Filippis EA, et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol. 2001;38(2):71–6.

Article  PubMed  Google Scholar 

Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke. 2005;36(8):1705–9.

Article  PubMed  Google Scholar 

Kim J-T, Lee JS, Kim BJ, Kang J, Lee K-J, Park J-M, et al. Admission hyperglycemia, stroke subtypes, outcomes in acute ischemic stroke. Diabetes Res Clin Pract. 2023;196: 110257.

Article  PubMed  Google Scholar 

Kruyt ND, Biessels GJ, DeVries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol. 2010;6(3):145–55.

Article  PubMed  Google Scholar 

Gresele P, Guglielmini G, De Angelis M, Ciferri S, Ciofetta M, Falcinelli E, et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol. 2003;41(6):1013–20.

Article  PubMed  Google Scholar 

Marfella R, Rizzo MR, Siniscalchi M, Paolisso P, Barbieri M, Sardu C, et al. Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage. Int J Cardiol. 2013;168(4):3954–62.

Article  PubMed  Google Scholar 

Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarction. J Am Coll Cardiol. 2003;41(1):1–7.

Article  PubMed  Google Scholar 

Yu Y, Wu Y, Wu X, Wang J, Wang C. Risk factors for no-reflow in patients with st-elevation myocardial infarction who underwent percutaneous coronary intervention: a case-control study. Cardiol Res Pract. 2022;2022(1):3482518.

PubMed  PubMed Central  Google Scholar 

Trongtorsak A, Kewcharoen J, Thangjui S, Yanez-Bello MA, Sous M, Prasai P, Navaravong L. Admission hyperglycemia in acute myocardial infarction is associated with an increased risk of arrhythmias: A systematic review and meta-analysis. J Arrhythm. 2022;38(3):307–15.

Article  PubMed  PubMed Central  Google Scholar 

Sun S, Pan Y, Zhao X, Liu L, Li H, He Y, et al. Prognostic value of admission blood glucose in diabetic and non-diabetic patients with intracerebral hemorrhage. Sci Rep. 2016;6(1):32342.

Article  PubMed  PubMed Central  Google Scholar 

Mondal S, DasGupta R, Lodh M, Garai R, Choudhury B, Hazra AK, et al. Stress hyperglycemia ratio, rather than admission blood glucose, predicts in-hospital mortality and adverse outcomes in moderate-to severe COVID-19 patients, irrespective of pre-existing glycemic status. Diabetes Res Clin Pract. 2022;190: 109974.

Article  PubMed  PubMed Central  Google Scholar 

Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, et al. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial. JAMA. 2019;322(4):326–35.

Article  PubMed  PubMed Central  Google Scholar 

Scott JF, Robinson GM, French JM, O’Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30(4):793–9.

Article  PubMed  Google Scholar 

Malmberg K, Rydén L, Efendic S, Herlitz J, Nicol P, Waldenström A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57–65.

Article  PubMed  Google Scholar 

Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26(7):650–61.

Article  PubMed  Google Scholar 

Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29(4):765–70.

Article  PubMed  Google Scholar 

Goyal A, Mehta SR, Díaz R, Gerstein HC, Afzal R, Xavier D, et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation. 2009;120(24):2429–37.